Page last updated: 2024-09-05

dronedarone and Bradyarrhythmia

dronedarone has been researched along with Bradyarrhythmia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belardinelli, L; Machado, AD; Nearing, BD; Sobrado, LF; Varone, BB; Verrier, RL; Zeng, D1
Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M1
Aliot, E; Capucci, A; Connolly, S; Crijns, H; Hohnloser, S; Immordino, L; Kowey, P; Radzik, D; Roy, D1

Trials

1 trial(s) available for dronedarone and Bradyarrhythmia

ArticleYear
Effect of dronedarone on cardiovascular events in atrial fibrillation.
    The New England journal of medicine, 2009, Feb-12, Volume: 360, Issue:7

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; Creatinine; Double-Blind Method; Dronedarone; Female; Follow-Up Studies; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Secondary Prevention; Treatment Outcome

2009

Other Studies

2 other study(ies) available for dronedarone and Bradyarrhythmia

ArticleYear
Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect.
    Journal of cardiovascular electrophysiology, 2013, Volume: 24, Issue:8

    Topics: Amiodarone; Analysis of Variance; Animals; Arterial Pressure; Benzazepines; Blood Pressure; Bradycardia; Diltiazem; Dronedarone; Isoproterenol; Ivabradine; Myocardial Contraction; Swine

2013
Effects of dronedarone started rapidly after amiodarone discontinuation.
    Clinical cardiology, 2013, Volume: 36, Issue:2

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Dronedarone; Drug Substitution; Female; Half-Life; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome

2013